Bias May Taint Big Pharma Research

Are researchers shilling for pharmaceutical companies in The New England Journal of Medicine? That’s the question raised by a Washington Post investigation that found that a disproportionate number of research articles in the leading journal were funded by drug companies and in many cases authored by a researcher who had accepted money from the company. And the journal is hardly the only offender. While the tangle of money and science may not lead directly to unscientific behavior, one can hypothesize that it increases the likelihood for some health-care hanky-panky.